Closing the Adherence Gap: How Point-of-Dispensing Pharmacy Intelligence Drives Adherence Outcomes

Pharmacies using EQUIPP Copilot™ closed year-end adherence gaps at 1.5 to 2 times the rate of documentation-only users, proving that point-of-dispensing intelligence is the decisive variable in pharmacy-based adherence outcomes.

The pharmacist access advantage: Patients visit community pharmacies nearly twice as often as primary care physicians, making the dispensing encounter the most consistent clinical touchpoint for chronic disease patients.
Enrollment alone isn't enough: Patient identification alone isn't enough: Knowing which patients are non-adherent creates no clinical value unless pharmacists can act on that insight at the most valuable time. 
Cognitive friction is the real barrier: Pharmacist intent is not the problem; workflow interruption required to retrieve adherence and medication related data from a separate system is what drives inconsistent engagement and patient outcomes.
Point-of-dispensing intelligence drives outcomes: When adherence data is surfaced automatically within the existing workflow, pharmacists act on it routinely, producing 15–21 percentage point population-level adherence lifts that are statistically significant at p < 0.000001.
While program enrollment creates the opportunity, point-of-dispensing intelligence determines whether that eligibility translates into measurable patient outcomes.

Download the white paper to see the full data.

Closing the Adherence Gap: How Point-of-Dispensing Pharmacy Intelligence Drives Adherence Outcomes

Pharmacies using EQUIPP Copilot™ closed year-end adherence gaps at 1.5 to 2 times the rate of documentation-only users, proving that point-of-dispensing intelligence is the decisive variable in pharmacy-based adherence outcomes.

The pharmacist access advantage: Patients visit community pharmacies nearly twice as often as primary care physicians, making the dispensing encounter the most consistent clinical touchpoint for chronic disease patients.
Enrollment alone isn't enough: Patient identification alone isn't enough: Knowing which patients are non-adherent creates no clinical value unless pharmacists can act on that insight at the most valuable time. 
Cognitive friction is the real barrier: Pharmacist intent is not the problem; workflow interruption required to retrieve adherence and medication related data from a separate system is what drives inconsistent engagement and patient outcomes.
Point-of-dispensing intelligence drives outcomes: When adherence data is surfaced automatically within the existing workflow, pharmacists act on it routinely, producing 15–21 percentage point population-level adherence lifts that are statistically significant at p < 0.000001.
While program enrollment creates the opportunity, point-of-dispensing intelligence determines whether that eligibility translates into measurable patient outcomes.

Download the white paper to see the full data.

Closing the Adherence Gap: How Point-of-Dispensing Pharmacy Intelligence Drives Adherence Outcomes

Pharmacies using EQUIPP Copilot™ closed year-end adherence gaps at 1.5 to 2 times the rate of documentation-only users, proving that point-of-dispensing intelligence is the decisive variable in pharmacy-based adherence outcomes.

The pharmacist access advantage: Patients visit community pharmacies nearly twice as often as primary care physicians, making the dispensing encounter the most consistent clinical touchpoint for chronic disease patients.
Enrollment alone isn't enough: Patient identification alone isn't enough: Knowing which patients are non-adherent creates no clinical value unless pharmacists can act on that insight at the most valuable time. 
Cognitive friction is the real barrier: Pharmacist intent is not the problem; workflow interruption required to retrieve adherence and medication related data from a separate system is what drives inconsistent engagement and patient outcomes.
Point-of-dispensing intelligence drives outcomes: When adherence data is surfaced automatically within the existing workflow, pharmacists act on it routinely, producing 15–21 percentage point population-level adherence lifts that are statistically significant at p < 0.000001.
While program enrollment creates the opportunity, point-of-dispensing intelligence determines whether that eligibility translates into measurable patient outcomes.

Download the white paper to see the full data.

Read the white paper
Fill out your details to access the white paper.
By submitting, you confirm that you agree to the processing of your personal data as described in the Privacy Statement.
Thank you!
Oops! Something went wrong while submitting the form.